24 hasil
Menampilkan 1–20 · 0,58 detik · RSS
Pigment International
ISSN 2349-5782 · Wolters Kluwer Medknow Publications · 24 artikel di indeks
-
Artikel Jurnal
Outcome measures in vitiligo: A narrative review
Vitiligo disease course being unpredictable in course, it is often difficult to monitor the response to therapy. Though there are many outcome measures, there is a lack of uniformity in reporting these across research papers and clinical trials making it challenging to interpret and compare the…
-
Artikel Jurnal
Advances in the etiopathogenesis of vitiligo
Vitiligo is a disorder that causes depigmentation of the skin and can impact an individual’s quality of life, especially in those with darker skin types due to the contrasting nature. Over the last 30 years, a rise in vitiligo focused research has been observed. Its etiopathogenesis has been…
-
Artikel Jurnal
Phototherapy in vitiligo
Vitiligo is a chronic dermatological condition characterized by the progressive loss of melanocytes, leading to depigmented patches on the skin. Phototherapy has emerged as a cornerstone in the management of vitiligo, offering a promising approach to disease stabilization and repigmentation. This…
-
Artikel Jurnal
A rare case of congenital vitiligo in a neonate with a review of literature
Congenital vitiligo is a very rare entity, but cases in infancy have been reported. We are presenting the case of a 2-month-old male infant who came to us with complaints of multiple progressive white patches over the body since birth. The lesions showed white accentuation with fluorescence under a…
-
Artikel Jurnal
Bullous pemphigoid after Split Skin grafting in vitiligo patient
Bullous pemphigoid (BP) is an autoimmune condition characterized by tense subepidermal blisters commonly seen in old age. Vitiligo is another autoimmune disease associated with loss of melanocytes. Very few cases of coexistence of vitiligo and BP are reported. A split skin graft (SSG) is a surgical…
-
Artikel Jurnal
Surgical modalities in the treatment of vitiligo
Vitiligo presents a challenge not only in its medical management but also in its impact on patients’ psychosocial well-being. While medical therapies can halt disease progression, achieving repigmentation, especially in challenging areas, remains a hurdle. Surgical interventions, including…
-
Artikel Jurnal
Medical treatment of vitiligo: A narrative review
Vitiligo, a chronic skin condition characterized by depigmentation, poses significant therapeutic challenges. Various medical therapies have been explored to address this disorder, aiming to halt its progression and promote repigmentation. Recent advancements in medical therapies have shown…
-
Artikel Jurnal
Vitiligo and cutaneous malignancy: what is the risk?
Vitiligo is a disorder of depigmentation affecting up to two percent of the global population. It is a long-held belief that patients with vitiligo have an increased risk for skin cancers due to the loss of melanin, a pigment which protects the skin against carcinogenesis. Phototherapy, a mainstay…
-
Artikel Jurnal
Lip vitiligo: a clinico-epidemiological study in a tertiary hospital of South India
Vitiligo is a common autoimmune pigmentary disorder characterized by destruction of functional melanocytes resulting in the appearance of depigmented patches on the skin and mucosa. These lesions pose a cosmetic challenge. The involvement of the mucosa is less, but may be the first symptom of this…
-
Artikel Jurnal
Association of sarcoidosis and vitiligo − sharing the autoimmune pathogenesis
The coexistence of vitiligo and sarcoidosis, although uncommon, has been reported rarely, suggesting the role of plasmacytoid dendritic cells in generating abnormal immune responses by Th1 and Th17-released cytokines. Our case is an interesting one, describing the co-existence of vitiligo and…
-
Artikel Jurnal
Metabolic syndrome and insulin resistance in patients with vitiligo: A cross-sectional study
Background: Vitiligo is nowadays considered a systemic disease owing to its complex, multifactorial pathogenesis. A possible association of vitiligo with metabolic syndrome as well as insulin resistance has been gaining interest recently. Shared factors in pathogenesis are being proposed as the…
-
Artikel Jurnal
Idiopathic eruptive macular pigmentation: a case series
Idiopathic eruptive macular pigmentation (IEMP) is a rare disorder of pigmentation presenting with asymptomatic hyperpigmentation mainly in children and adolescents over face, neck, trunk, and extremities. Epidermal basal-cell pigmentation is observed on histopathology. It usually resolves…
-
Artikel Jurnal
Intradermal platelet-rich plasma vs. 1064 nm Q switched Nd-YAG laser (Qs Nd-YAG) in the treatment of resistant melasma − A split face comparative study in Indian subjects
Background: Melasma is a common dermatosis in both men and women showing varying degrees of success with treatment. Relapse of pigmentation in melasma after treatment is a common problem in dark skin types that necessitates treatment with novel alternative modalities with better efficacy. Aim: To…
-
Artikel Jurnal
A randomized comparative study of efficacy of microneedling with 5% 5-FU and microneedling with 0.1% tacrolimus in treatment of vitiligo
Background: Vitiligo is an amelanotic disorder affecting 0.5% to 2% of the world’s population. Several treatment modalities have been tried and it has been reported that combination therapies augment the repigmentation in vitiligo. Objective: To compare the efficacy of microneedling with 5% 5-FU…
-
Artikel Jurnal
Quality of life scales in pigmentary disorders
Pigmentary disorders, especially vitiligo and melasma, are cosmetically disfiguring and have a profound impact on life quality. Various quality of life tools and questionnaires have been devised in order to objectively quantify this psychosocial morbidity, which can guide towards more comprehensive…